FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
2012
Despite the success in treating the majority of children with newly diagnosed acute leukemia, children with relapsed or refractory disease are an exceptionally difficult group of patients to cure. We assessed the combination of fludarabine with cytarabine and granulocyte colony-stimulating factor (F
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
14
Citations
NaN
KQI